Similar articles for PMID: 26843897

Year	Number of Results
2004	1
2005	2
2006	2
2008	6
2009	9
2010	6
2011	2
2012	3
2013	12
2014	11
2015	5
2016	4
2017	9
2018	2
2019	6
2020	10
2021	6
2022	8
2023	7
2024	1

1

Bioequivalence of Alendronate and Vitamin D3 in a Combination Tablet Versus Corresponding-Dose Individual Tablets in Healthy Taiwanese Volunteers, Determined Using a Novel Plasma Alendronate Assay.

Wright DH, Mols R, Brown KR, Yeh GC, Woolf E, Hickey L, Zajic S. Wright DH, et al. Curr Ther Res Clin Exp. 2015 Oct 14;77:116-21. doi: 10.1016/j.curtheres.2015.10.001. eCollection 2015 Dec. Curr Ther Res Clin Exp. 2015. PMID: 26843897 Free PMC article.

2

Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tablet.

Denker AE, Lazarus N, Porras A, Ramakrishnan R, Constanzer M, Scott BB, Chavez-Eng C, Woolf E, Maganti L, Larson P, Gottesdiener K, Wagner JA. Denker AE, et al. J Clin Pharmacol. 2011 Oct;51(10):1439-48. doi: 10.1177/0091270010382010. Epub 2010 Dec 8. J Clin Pharmacol. 2011. PMID: 21148044 Clinical Trial.

3

Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.

Zhang ZL, Liao EY, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, De Peng Y, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L, Santora AC. Zhang ZL, et al. Osteoporos Int. 2015 Sep;26(9):2365-74. doi: 10.1007/s00198-015-3141-y. Epub 2015 May 1. Osteoporos Int. 2015. PMID: 25929192 Free PMC article. Clinical Trial.

4

Comparison of the pharmacokinetics, safety, and tolerability of vitamin D3 in DP-R206 (150-mg ibandronate/24,000-IU vitamin D3 tablet) and as monotherapy (24,000 iu) in healthy male Korean adults.

Jeon JY, Lee SY, Im YJ, Kim EY, Kim Y, Park TS, Chae SW, Lee JW, Jun H, Lee TW, Kim MG. Jeon JY, et al. Clin Ther. 2014 Jan 1;36(1):48-57. doi: 10.1016/j.clinthera.2013.12.001. Epub 2013 Dec 28. Clin Ther. 2014. PMID: 24378207 Clinical Trial.

5

Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.

Sun F, Liu Y, Li T, Lin P, Jiang X, Li X, Wang C, Gao X, Ma Y, Fu Y, Cao Y. Sun F, et al. BMC Pharmacol Toxicol. 2023 Feb 3;24(1):7. doi: 10.1186/s40360-023-00649-y. BMC Pharmacol Toxicol. 2023. PMID: 36737825 Free PMC article. Clinical Trial.

6

Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.

Cho HY, Yoon H, Lim YC, Lee YB. Cho HY, et al. Int J Clin Pharmacol Ther. 2009 Dec;47(12):770-9. doi: 10.5414/cpp47770. Int J Clin Pharmacol Ther. 2009. PMID: 19954716 Clinical Trial.

7

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.

Binkley N, Ringe JD, Reed JI, Ljunggren O, Holick MF, Minne HW, Liu M, Lamotta A, West JA, Santora AC. Binkley N, et al. Bone. 2009 Apr;44(4):639-47. doi: 10.1016/j.bone.2008.05.002. Epub 2008 May 15. Bone. 2009. PMID: 19185560 Clinical Trial.

8

Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).

Nakade S, Komaba J, Ohno T, Kitagawa J, Furukawa K, Miyata Y. Nakade S, et al. Int J Clin Pharmacol Ther. 2008 Jan;46(1):42-7. doi: 10.5414/cpp46042. Int J Clin Pharmacol Ther. 2008. PMID: 18218297 Clinical Trial.

9

Bioequivalence of generic alendronate sodium tablets (70 mg) to Fosamax^® tablets (70 mg) in fasting, healthy volunteers: a randomized, open-label, three-way, reference-replicated crossover study.

Zhang Y, Chen X, Tang Y, Lu Y, Guo L, Zhong D. Zhang Y, et al. Drug Des Devel Ther. 2017 Jul 11;11:2109-2119. doi: 10.2147/DDDT.S138286. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28744102 Free PMC article. Clinical Trial.

10

Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation.

Bone HG, Walter MA, Hurley ME, Epstein S. Bone HG, et al. Osteoporos Int. 2017 May;28(5):1745-1752. doi: 10.1007/s00198-017-3941-3. Epub 2017 Feb 16. Osteoporos Int. 2017. PMID: 28204953 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year